Skip to Main Content

Paper Details

Design of a stable human acid-β-glucosidase: towards improved Gaucher disease therapy and mutation classification.
FEBS J
3
2023
Acid--glucosidase, EC3.2.1.45, GBA1, GBA1 gene, GBA1 mutations, GCase, GCase variants, GD, Gaucher disease, GlcCer, PD, Parkinson's disease, Recombinant GCase, cultured cells, glucosylceramide, human, human acid--glucosidase, inherited metabolic disorder, neurological, patients, single-nucleotide polymorphisms, wild-type human GCase
Author NameAffiliation
Yoav PelegWeizmann Institute of Science
Tamar UngerWeizmann Institute of Science
Shira AlbeckWeizmann Institute of Science
Orly DymWeizmann Institute of Science
Joel L SussmanWeizmann Institute of Science
Sarel J FleishmanWeizmann Institute of Science
  • 1 - 6

Datasets

Release 1.2